U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07403058) titled 'Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects With Reduced Ejection Fraction' on Jan. 29.
Brief Summary: This study is a small, early-stage clinical trial designed to test whether a new catheter-based procedure is safe and may help people with heart failure with reduced ejection fraction (HFrEF). The procedure uses the Satera Ablation System to treat the right greater splanchnic nerve, which may play a role in heart failure symptoms. The study also aims to identify which types of patients might benefit most from this treatment in the future.
Up to 50 patients aged 40 or older with HFrEF will take part at a...